Elevated dipeptidyl peptidase 3 predicts morbidity and mortality in cardiogenic shock: pre-specified secondary analyses from the accost-hh trial

enibarcimab (HAM8101) - Adrenomed

M Karakas 1; A Picod 2; H Nordin 2; T Zeller 3; C Oddos 2; K Santos 4; D Jarczak 5; A Mebazaa 5; F Azibani 2; S Kluge 5

Mar 19, 2024